Julian Andreev Regeneron Pharmaceuticals Inc, USA
1 protocol

Nithya Thambi Regeneron Pharmaceuticals Inc, USA
1 protocol

Laura Winters Regeneron Pharmaceuticals Inc, USA
1 protocol

Frank Kuhnert
  • Regeneron Pharmaceuticals Inc, USA
Research focus
  • Cancer biology
  • 1 Author merit
1 Protocol published
采用HUVEC纤维蛋白珠催芽试验评估血管生成抑制因子
Authors:  Laura Winters, Nithya Thambi, Julian Andreev and Frank Kuhnert, date: 10/05/2016, view: 11353, Q&A: 0
Angiogenesis, the growth of new blood vessels from pre-existing vessels, is a critical process that occurs during normal development and tumor formation. Targeting tumor angiogenesis by blocking the activity of vascular endothelial growth factor ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.